Developing a cancer‐specific trigger tool to identify treatment‐related adverse events using administrative data-Reference-Cited by-同舟云学术

Developing a cancer‐specific trigger tool to identify treatment‐related adverse events using administrative data

Published:2020-01-03 Issue:4 Volume:9 Page:1462-1472
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Weingart Saul N.¹²³^ORCID,Nelson Jason⁴,Koethe Benjamin⁴,Yaghi Omar¹,Dunning Stephan³,Feldman Albert³,Kent David M.¹²⁴,Lipitz‐Snyderman Allison⁵^ORCID

Affiliation:

1. Tufts Medical Center Boston MA USA

2. Department of Medicine Tufts University School of Medicine Boston MA USA

3. OptumLabs Cambridge MA USA

4. Predictive Analytics and Comparative Effectiveness Center Tufts University School of Medicine Boston MA USA

5. Memorial Sloan Kettering Cancer Center New York NY USA

Funder

AARP Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2812

Reference39 articles.

1. AllenS.With work Dana‐Farber learns from ‘94 mistakes.The Boston Globe.2004.http://archive.boston.com/news/local/articles/2004/11/30/with_work_dana_farber_learns_from_94_mistakes/. Accessed 18 August 2019.

2. Medication safety in the ambulatory chemotherapy setting

3. Medication Errors Among Adults and Children With Cancer in the Outpatient Setting

4. Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum

5. Chemotherapy medication errors

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapy;Frontiers in Immunology;2024-07-05

2. The application of Global Trigger Tool in monitoring antineoplastic adverse drug events: a retrospective study;Frontiers in Oncology;2024-05-08

3. Utility of a Clinically Guided Data-Driven Approach for Predicting Breast Cancer Complications: An Application Using a Population-Based Claims Data Set;JCO Clinical Cancer Informatics;2022-11

4. Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group;Pediatric Blood & Cancer;2022-09-09

5. A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning;Frontiers in Pharmacology;2022-06-29